| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 12.023 | 13.171 | 10.047 | 13.730 | 20.515 | 22.753 | 23.289 | 23.776 |
| Total Income - EUR | - | - | 12.023 | 13.171 | 10.047 | 13.730 | 20.515 | 22.753 | 23.289 | 23.776 |
| Total Expenses - EUR | - | - | 1.835 | 1.363 | 105 | 128 | 198 | 158 | 1.826 | 968 |
| Gross Profit/Loss - EUR | - | - | 10.187 | 11.808 | 9.942 | 13.602 | 20.317 | 22.595 | 21.463 | 22.808 |
| Net Profit/Loss - EUR | - | - | 9.826 | 11.413 | 9.640 | 13.211 | 19.704 | 21.926 | 18.544 | 19.232 |
| Employees | - | - | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Damian Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 15.715 | 19.553 | 16.469 | 20.836 | 26.577 | 31.358 | 37.006 | 28.207 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 2.916 | 1.852 | 1.070 | 1.087 | 1.942 | 16.530 | 1.578 | 15.024 |
| Cash | - | - | 12.799 | 17.701 | 15.400 | 19.749 | 24.635 | 14.828 | 35.428 | 13.183 |
| Shareholders Funds | - | - | 12.093 | 13.639 | 11.822 | 15.352 | 21.798 | 21.974 | 26.174 | 19.280 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 3.621 | 5.914 | 4.647 | 5.485 | 4.780 | 9.384 | 10.832 | 8.927 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Damian Med Srl